@andrewrdunn.bsky.social
Reposted
Stop by and meet the Moffitt team at the #AACR25 Career Fair! Learn about career opportunities and how we’re advancing cancer research and care. #MoffittAACR25
@theaacr.bsky.social
@theaacr.bsky.social
April 25, 2025 at 7:17 PM
Stop by and meet the Moffitt team at the #AACR25 Career Fair! Learn about career opportunities and how we’re advancing cancer research and care. #MoffittAACR25
@theaacr.bsky.social
@theaacr.bsky.social
Reposted
Facing a tough biotech market, Caribou will cut 32% of staff and shelve its lupus and AML programs to refocus on blood cancer cell therapies.
Caribou lays off 32% of staff, cuts lupus cell therapy program before first patient
Caribou Biosciences is paring down its pipeline and cutting about a third of its workforce as cell and gene therapy companies continue to struggle amid a bleak biotech market.
endpts.com
April 25, 2025 at 2:01 PM
Facing a tough biotech market, Caribou will cut 32% of staff and shelve its lupus and AML programs to refocus on blood cancer cell therapies.